Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10685668 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Combination Chemotherapy, Interferon Alfa, and Interleukin-2 in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: aldesleukin;   Biological: recombinant interferon alfa;   Drug: cisplatin;   Drug: dacarbazine

Indicates status has not been verified in more than two years